|
DK365785A
(da)
*
|
1984-09-17 |
1986-03-18 |
Hoffmann La Roche |
Metalcomplexer
|
|
US5075447A
(en)
*
|
1984-09-17 |
1991-12-24 |
Hoffmann-La Roche Inc. |
Ruthenium complexes useful as carriers for immunologically active materials
|
|
GB8601646D0
(en)
|
1986-01-23 |
1986-02-26 |
Davidson R S |
Binding assay & reagent
|
|
US5585279A
(en)
*
|
1986-01-23 |
1996-12-17 |
Davidson; Robert S. |
Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
|
|
US6018030A
(en)
*
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
DE69028552T2
(de)
|
1989-12-28 |
1997-03-06 |
The Upjohn Co., Kalamazoo, Mich. |
Diaromatische substituierte verbindungen gegen den aids-virus
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
AU4017695A
(en)
|
1994-10-28 |
1996-05-23 |
Procept, Inc. |
Ruthenium complexes and their use as immunosuppressive agents
|
|
US5708022A
(en)
*
|
1994-10-28 |
1998-01-13 |
Procept, Inc. |
Method for inhibiting immune response
|
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
|
US5831003A
(en)
|
1996-06-28 |
1998-11-03 |
Bayer Corporation |
Peptides which bind to prothrombin and thrombin
|
|
NZ502303A
(en)
|
1997-06-18 |
2002-02-01 |
Ulrich J Krull |
Nucleic acid biosensor system & diagnostic use
|
|
WO1999031513A1
(en)
|
1997-12-15 |
1999-06-24 |
Lakowicz Joseph R |
Method and composition for characterizing a sample containing a sample lipid and an assay kit
|
|
US6759243B2
(en)
*
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
|
ES2299244T3
(es)
*
|
1998-05-13 |
2008-05-16 |
Domantis Limited |
Sistema de exposicion de fagos para la seleccion de proteinas correctamente plegadas.
|
|
EP1077989A4
(en)
*
|
1998-05-13 |
2002-01-02 |
Ludwig Inst Cancer Res |
ANTIGEN WITH TUMOR ASSOCIATION ENCODED BY THE ANTISENSE STRAND OF A NEW GENE WITH UBIQUISTIC EXPRESSION
|
|
US7037667B1
(en)
*
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
|
US7521197B2
(en)
*
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
|
US20020106678A1
(en)
*
|
1998-06-30 |
2002-08-08 |
Robishaw Janet D. |
cDNA clones encoding human G protein gamma subunits
|
|
JP2002519428A
(ja)
|
1998-07-02 |
2002-07-02 |
メルク エンド カムパニー インコーポレーテッド |
プレニル−タンパク質トランスフェラーゼの阻害剤
|
|
US6288221B1
(en)
*
|
1998-08-20 |
2001-09-11 |
Duke University |
Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
|
|
US6806089B1
(en)
*
|
1998-09-08 |
2004-10-19 |
University Of Maryland, Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
|
AU6136599A
(en)
|
1998-09-08 |
2000-03-27 |
University Of Maryland At Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
|
AU1223400A
(en)
*
|
1998-10-22 |
2000-05-08 |
Phillip B. B. Moheno |
Novel pterin antineoplastic agents
|
|
AU3268500A
(en)
|
1999-03-19 |
2000-10-09 |
Anormed Inc. |
Pharmaceutical compositions comprising metal complexes
|
|
US6872519B1
(en)
*
|
1999-04-27 |
2005-03-29 |
Mirus Bio Corporation |
In vitro process for selecting phage resistant to blood inactivation
|
|
US20090087878A9
(en)
*
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
US20030024579A1
(en)
|
1999-07-07 |
2003-02-06 |
Blackmore Donald Ian |
Diverter valve
|
|
GB9916529D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
|
CZ2002959A3
(cs)
|
1999-09-17 |
2002-07-17 |
Millennium Pharmaceuticals, Inc. |
Inhibitory faktoru Xa
|
|
WO2001046209A1
(en)
|
1999-12-20 |
2001-06-28 |
Fluorrx, Inc. |
Fluorescent probes
|
|
US20030219806A1
(en)
*
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
|
US7585839B2
(en)
*
|
2000-02-23 |
2009-09-08 |
Zealand Pharma A/S |
Medical uses of intercellular communication facilitating compounds
|
|
US20030215860A1
(en)
*
|
2000-02-29 |
2003-11-20 |
Millennium Pharmaceuticals, Inc. |
Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
|
|
WO2001070979A2
(en)
*
|
2000-03-21 |
2001-09-27 |
Millennium Pharmaceuticals, Inc. |
Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
US7834146B2
(en)
*
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
|
WO2001098468A2
(en)
*
|
2000-06-16 |
2001-12-27 |
Incyte Genomics, Inc. |
Proteases
|
|
WO2002006339A2
(en)
*
|
2000-07-03 |
2002-01-24 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US20050053930A1
(en)
*
|
2000-07-18 |
2005-03-10 |
David Anderson |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US6812339B1
(en)
*
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
US7264810B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
TW200526779A
(en)
*
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
US6783969B1
(en)
*
|
2001-03-05 |
2004-08-31 |
Nuvelo, Inc. |
Cathepsin V-like polypeptides
|
|
US7030236B2
(en)
|
2001-03-09 |
2006-04-18 |
Mona Savitri Jhaveri |
Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof
|
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
US20030065157A1
(en)
|
2001-04-04 |
2003-04-03 |
Lasek Amy W. |
Genes expressed in lung cancer
|
|
WO2002083921A2
(en)
*
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
AU2002309583A1
(en)
*
|
2001-04-18 |
2002-11-05 |
Protein Desing Labs, Inc. |
Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
|
|
WO2002102235A2
(en)
*
|
2001-06-18 |
2002-12-27 |
Eos Biotechnology Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
US20040053824A1
(en)
*
|
2001-06-29 |
2004-03-18 |
Tang Y Tom |
Extracellular matrix and cell adhesion molecules
|
|
US20030099974A1
(en)
*
|
2001-07-18 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
KR20100043294A
(ko)
|
2001-08-31 |
2010-04-28 |
비티지 인터내셔널 리미티드 |
항암제로서 사용되는 시클로펜타[ｇ]퀴나졸린 화합물
|
|
US7528141B2
(en)
|
2001-08-31 |
2009-05-05 |
Btg International Limited |
Use of cyclopenta[g]quinazoline derivatives for treating cancer
|
|
US7622260B2
(en)
|
2001-09-05 |
2009-11-24 |
The Brigham And Women's Hospital, Inc. |
Diagnostic and prognostic tests
|
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
AR045702A1
(es)
*
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
BR0214295A
(pt)
|
2001-11-19 |
2004-11-09 |
Elan Pharm Inc |
Composto, método para tratar um paciente que tem ou prevenir um paciente de adquirir uma doença ou condição, e, método para produzir um composto
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
WO2003057725A2
(en)
*
|
2002-01-09 |
2003-07-17 |
University Of Lausanne |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
WO2003062290A1
(en)
|
2002-01-16 |
2003-07-31 |
Biocompatibles Uk Limited |
Polymer conjugates
|
|
EP1478328B1
(en)
*
|
2002-01-28 |
2013-06-05 |
Keraplast Technologies Ltd. |
Bioactive keratin peptides
|
|
US6962910B2
(en)
*
|
2002-02-01 |
2005-11-08 |
Virginia Tech Intellectual Properties, Inc. |
Supramolecular complexes as photoactivated DNA cleavage agents
|
|
WO2003068054A2
(en)
*
|
2002-02-13 |
2003-08-21 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health Services |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
DE10206616A1
(de)
*
|
2002-02-15 |
2003-09-04 |
Qiagen Gmbh |
Verfahren zur Reduktion der Background-Kontamination nach Markierungsreaktionen
|
|
AU2003228267A1
(en)
|
2002-03-05 |
2003-09-22 |
Board Of Regents, The University Of Texas System |
Methods of enhancing immune induction involving mda-7
|
|
US20040101874A1
(en)
*
|
2002-04-12 |
2004-05-27 |
Mitokor Inc. |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
|
PL375064A1
(en)
*
|
2002-05-20 |
2005-11-14 |
Abgenix, Inc. |
Treatment of renal carcinoma using antibodies against the egfr
|
|
AU2003295328A1
(en)
*
|
2002-10-02 |
2004-04-23 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1422242A1
(en)
|
2002-11-22 |
2004-05-26 |
Emory University |
Plastic and elastic protein copolymers
|
|
JP2006519008A
(ja)
*
|
2003-02-10 |
2006-08-24 |
独立行政法人産業技術総合研究所 |
哺乳動物細胞の調節
|
|
WO2004087874A2
(en)
|
2003-03-28 |
2004-10-14 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
AU2004240765B2
(en)
*
|
2003-05-20 |
2009-03-19 |
Cellpep Sa |
Modified antiviral peptides with increased activity and cell membrane affinity
|
|
CA2526393A1
(en)
*
|
2003-05-21 |
2004-12-02 |
Genesense Technologies Inc. |
Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
|
|
US20060078941A1
(en)
|
2003-06-09 |
2006-04-13 |
Santin Alessandro D |
Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
|
|
WO2006003352A1
(en)
|
2004-07-06 |
2006-01-12 |
Warwick Effect Polymers Limited |
Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
|
|
GB0314472D0
(en)
*
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
|
GB0318096D0
(en)
*
|
2003-08-01 |
2003-09-03 |
Queen Mary & Westfield College |
Vaccine
|
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
US20050147621A1
(en)
*
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
|
DE10347710B4
(de)
*
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
US7202234B2
(en)
*
|
2003-10-24 |
2007-04-10 |
Eisai Co., Ltd. |
Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
|
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
|
EP1547581A1
(en)
|
2003-12-23 |
2005-06-29 |
Vectron Therapeutics AG |
Liposomal vaccine for the treatment of human hematological malignancies
|
|
EP1550458A1
(en)
*
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
WO2005066337A2
(en)
*
|
2004-01-09 |
2005-07-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
|
|
CA2555145A1
(en)
|
2004-02-06 |
2005-08-25 |
Wyeth |
Diagnosis and therapeutics for cancer
|
|
JP4912894B2
(ja)
|
2004-02-19 |
2012-04-11 |
イェール ユニバーシティー |
プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
|
|
EA200601575A1
(ru)
|
2004-03-01 |
2007-06-29 |
Пептера Фармасьютикалс Лтд. |
Казеиновые пептиды и их терапевтическое применение
|
|
WO2007084413A2
(en)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7772271B2
(en)
*
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7553944B2
(en)
*
|
2004-07-21 |
2009-06-30 |
The University Of Hong Kong |
Human virus causing respiratory tract infection and uses thereof
|
|
US20080280317A1
(en)
*
|
2004-08-27 |
2008-11-13 |
Northeastern University |
Comprehensive Characterization Of Complex Proteins At Trace Levels
|
|
DE102004042546A1
(de)
*
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
JP2008512490A
(ja)
|
2004-09-08 |
2008-04-24 |
チェルシー・セラピューティクス，インコーポレイテッド |
異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤
|
|
US8247371B2
(en)
|
2004-10-14 |
2012-08-21 |
Yale University |
Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer
|
|
WO2006050247A2
(en)
*
|
2004-10-29 |
2006-05-11 |
Neose Technologies, Inc. |
Remodeling and glycopegylation of fibroblast growth factor (fgf)
|
|
JP2008526749A
(ja)
*
|
2005-01-04 |
2008-07-24 |
ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド |
自己アセンブリするペプチドナノファイバーを用いたｐｄｇｆの徐放性の送達
|
|
US7531533B2
(en)
*
|
2005-01-27 |
2009-05-12 |
Asahi Kasei Pharma Corporation |
6-Membered heterocyclic compound and use thereof
|
|
EP1847533B1
(en)
|
2005-01-27 |
2013-08-14 |
Asahi Kasei Pharma Corporation |
Six-membered heterocyclic compound and the use thereof
|
|
US8007811B2
(en)
*
|
2005-02-14 |
2011-08-30 |
Epitopix, Llc |
Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
|
|
CN101160524A
(zh)
*
|
2005-02-24 |
2008-04-09 |
西米尼斯公司 |
用于生物样品分类的组合物和方法
|
|
EP1863800A4
(en)
|
2005-03-17 |
2011-05-04 |
Harvard College |
SYNTHESIS OF AVRAINVILLAMID, STEPHACIDINE B AND ANALOGUE THEREOF
|
|
FR2885525B1
(fr)
*
|
2005-05-13 |
2009-09-18 |
Urodelia Sa |
Medicament notamment anti-cancereux, destine a des traitements par immunotherapie, en particulier autologue
|
|
KR101604799B1
(ko)
*
|
2005-06-13 |
2016-03-28 |
클리브랜드 바이오랩스, 아이엔씨. |
리포펩티드를 사용하여 아폽토시스에 대항하는 보호방법
|
|
WO2006138380A2
(en)
|
2005-06-15 |
2006-12-28 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
BRPI0612287A8
(pt)
|
2005-06-27 |
2019-01-22 |
Exelixis Inc |
composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear
|
|
WO2007005249A2
(en)
|
2005-06-29 |
2007-01-11 |
Hyperbranch Medical Technology, Inc. |
Nanoparticles and dendritic-polymer-based hydrogels comprising them
|
|
US7494788B2
(en)
*
|
2005-07-11 |
2009-02-24 |
Molecular Kinetics, Inc. |
Entropic bristle domain sequences and their use in recombinant protein production
|
|
US7820790B2
(en)
*
|
2005-07-13 |
2010-10-26 |
Amgen Mountain View Inc. |
IL-6 binding proteins
|
|
GB0516058D0
(en)
|
2005-08-04 |
2005-09-14 |
Oxford Genome Sciences Uk Ltd |
New protein isoforms and uses thereof
|
|
GB0517293D0
(en)
|
2005-08-24 |
2005-10-05 |
Cancer Rec Tech Ltd |
Vectors and uses thereof
|
|
PL1931998T3
(pl)
*
|
2005-09-15 |
2010-11-30 |
Alk Abello As |
Sposób ilościowego oznaczania alergenów
|
|
WO2007073432A2
(en)
|
2005-10-11 |
2007-06-28 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
AU2006303037A1
(en)
|
2005-10-21 |
2007-04-26 |
Merz Pharma Gmbh & Co Kgaa |
Chromenones and their use as modulators of metabotropic glutamate receptors
|
|
UA96139C2
(uk)
*
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
DK1954274T3
(da)
*
|
2005-11-10 |
2011-01-31 |
Chemocentryx Inc |
Substituerede quinoloner og fremgangsmåder til anvendelse
|
|
EP1954134B1
(en)
|
2005-11-23 |
2011-09-14 |
Merck Sharp & Dohme Corp. |
Process for synthesizing a 2-phenyl-1h-phenantrho[9,10-d]imidazole derivative
|
|
KR101049859B1
(ko)
|
2007-11-28 |
2011-07-19 |
대한민국 |
Ｎ-말단 ｐＩ 값 조절에 의한 수용성 재조합 단백질 생산방법
|
|
WO2007101441A1
(en)
*
|
2006-03-06 |
2007-09-13 |
Symphogen A/S |
Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
|
|
JP5167155B2
(ja)
|
2006-03-09 |
2013-03-21 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
ペプチド結合に基づく多数の細胞株のプロファイリングに関連した組成物および方法
|
|
CA2642819C
(en)
|
2006-03-10 |
2015-06-09 |
Warwick Effect Polymers Ltd. |
Sugar polymers
|
|
WO2007110755A1
(en)
|
2006-03-27 |
2007-10-04 |
Medical Therapies Limited |
Prophylaxis or treatment of cardiovascular inflammation
|
|
JP5093783B2
(ja)
*
|
2006-04-20 |
2012-12-12 |
クリングルファーマ株式会社 |
Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
|
|
WO2007131191A2
(en)
*
|
2006-05-05 |
2007-11-15 |
Perkinelmer Life And Analytical Sciences |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
|
CA2652247C
(en)
|
2006-05-08 |
2015-11-17 |
Adaerata, Limited Partnership |
Chimeric pcsk9 proteins, cells comprising same, and assays using same
|
|
ES2444695T3
(es)
*
|
2006-06-23 |
2014-02-26 |
Alethia Biotherapeutics Inc. |
Polinucleótidos y polipéptidos implicados en el cáncer
|
|
NL1032064C2
(nl)
*
|
2006-06-27 |
2008-01-02 |
Walraven Holding Bv J Van |
Pijpbeugel met trillingisolerende inlaag.
|
|
EP2041556A1
(en)
|
2006-06-28 |
2009-04-01 |
RGB Technologies AB |
A sensor kit and a system for detecting an analyte in a test environment
|
|
US8198046B2
(en)
*
|
2006-07-11 |
2012-06-12 |
Danisco Us Inc. |
KEX2 cleavage regions of recombinant fusion proteins
|
|
EP2049144B8
(en)
*
|
2006-07-21 |
2015-02-18 |
ratiopharm GmbH |
Glycosylation of peptides via o-linked glycosylation sequences
|
|
WO2008012362A2
(en)
*
|
2006-07-27 |
2008-01-31 |
Oxford Genome Sciences (Uk) Ltd |
New protein isoforms and uses thereof
|
|
EP2052088A2
(en)
*
|
2006-08-02 |
2009-04-29 |
Genizon Biosciences |
Genemap of the human genes associated with psoriasis
|
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
|
WO2008029031A2
(fr)
*
|
2006-09-07 |
2008-03-13 |
Laurence Faure |
Test pharmaco diagnostique ciblant l' oncologie
|
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
|
CN101663308A
(zh)
*
|
2006-10-30 |
2010-03-03 |
桑尔克斯药品公司 |
N-甲基色胺钙五水合物(dcp)和基于它的治疗方法
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
CA2672860C
(en)
|
2006-12-28 |
2013-01-29 |
Abbott Laboratories |
Inhibitors of poly(adp-ribose)polymerase
|
|
WO2008086426A2
(en)
*
|
2007-01-09 |
2008-07-17 |
Cleveland Biolabs, Inc. |
Methods for increasing and mobilizing hematopoietic stem cells
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
WO2008124483A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
|
JP2010526091A
(ja)
*
|
2007-04-30 |
2010-07-29 |
インテザイン テクノロジーズ， インコーポレイテッド |
癌の処置のための生物学的な標的基の改変
|
|
US20080306007A1
(en)
*
|
2007-04-30 |
2008-12-11 |
Newcastle Innovation Limited |
Agents for prophylaxis or treatment of neurological related diseases and conditions
|
|
US8143372B2
(en)
*
|
2007-05-21 |
2012-03-27 |
Children's Hospital & Research Center Oakland |
Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
|
|
US20090176664A1
(en)
*
|
2007-06-01 |
2009-07-09 |
Keting Chu |
High density peptide arrays containing kinase or phosphatase substrates
|
|
US8618121B2
(en)
|
2007-07-02 |
2013-12-31 |
Cancer Research Technology Limited |
9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
|
|
US9018138B2
(en)
*
|
2007-08-16 |
2015-04-28 |
The Johns Hopkins University |
Compositions and methods for generating and screening adenoviral libraries
|
|
CA2695309A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Symphogen A/S |
Methods for recombinant manufacturing of anti-rsv antibodies
|
|
GB0719644D0
(en)
|
2007-10-05 |
2007-11-14 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
US20100298368A1
(en)
|
2007-11-06 |
2010-11-25 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
|
WO2009111088A2
(en)
|
2008-01-02 |
2009-09-11 |
The Johns Hopkins University |
Antitumor immunization by liposomal delivery of vaccine to the spleen
|
|
US8568709B2
(en)
|
2008-03-20 |
2013-10-29 |
University Health Network |
Thymidylate kinase fusions and uses thereof
|
|
ES2500616T3
(es)
*
|
2008-05-09 |
2014-09-30 |
Evonik Corporation |
Polímeros elastoméricos biocompatibles y biodegradables
|
|
EP2772251B1
(en)
|
2008-05-26 |
2021-03-03 |
Universität Zürich |
Protamine/RNA nanoparticles for immunostimulation
|
|
US8071807B2
(en)
|
2008-07-03 |
2011-12-06 |
Panmira Pharmaceuticals, Llc |
Antagonists of prostaglandin D2 receptors
|
|
US8148088B2
(en)
*
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
|
EP2309853A4
(en)
|
2008-08-01 |
2012-04-25 |
Lixte Biotechnology Inc |
METHOD FOR CELL MITITULATING BY INHIBITION OF SERIN / THREONINE PHOSPHATASE
|
|
US9126953B2
(en)
|
2008-08-08 |
2015-09-08 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
CA2740900C
(en)
|
2008-11-03 |
2019-09-24 |
Alethia Biotherapeutics Inc. |
Antibodies that specifically block the biological activity of a tumor antigen
|
|
WO2011054112A1
(en)
|
2009-11-03 |
2011-05-12 |
Alethia Biotherapeutics Inc. |
Antibodies that specifically block the biological activity of kidney associated antigen 1
|